Global Bispecific Antibodies Market Research Report 2024(Status and Outlook)

Global Bispecific Antibodies Market Research Report 2024(Status and Outlook)



Report Overview:

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.

The Global Bispecific Antibodies Market Size was estimated at USD 3400.83 million in 2023 and is projected to reach USD 4156.31 million by 2029, exhibiting a CAGR of 3.40% during the forecast period.

This report provides a deep insight into the global Bispecific Antibodies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bispecific Antibodies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bispecific Antibodies market in any manner.

Global Bispecific Antibodies Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche Holding AG

GenScript

Sino Biological Inc.

Creative-Biolabs

AbbVie Inc.

Kymab

AstraZeneca

BIOCYTOGEN

Amgen Inc.

Pfizer Inc.

Novartis AG

Johnson & Johnson

ProteoGenix

Market Segmentation (by Type)

Blinatumab

Catumaxomab

Duligotumab

Market Segmentation (by Application)

Cancer

Infectious Disease

Inflammatory and Autoimmune Disorders

CNS Disorders

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Bispecific Antibodies Market

Overview of the regional outlook of the Bispecific Antibodies Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Bispecific Antibodies Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bispecific Antibodies
1.2 Key Market Segments
1.2.1 Bispecific Antibodies Segment by Type
1.2.2 Bispecific Antibodies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bispecific Antibodies Market Overview
2.1 Global Market Overview
2.1.1 Global Bispecific Antibodies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Bispecific Antibodies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bispecific Antibodies Market Competitive Landscape
3.1 Global Bispecific Antibodies Sales by Manufacturers (2019-2024)
3.2 Global Bispecific Antibodies Revenue Market Share by Manufacturers (2019-2024)
3.3 Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bispecific Antibodies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Bispecific Antibodies Sales Sites, Area Served, Product Type
3.6 Bispecific Antibodies Market Competitive Situation and Trends
3.6.1 Bispecific Antibodies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bispecific Antibodies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bispecific Antibodies Industry Chain Analysis
4.1 Bispecific Antibodies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bispecific Antibodies Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bispecific Antibodies Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bispecific Antibodies Sales Market Share by Type (2019-2024)
6.3 Global Bispecific Antibodies Market Size Market Share by Type (2019-2024)
6.4 Global Bispecific Antibodies Price by Type (2019-2024)
7 Bispecific Antibodies Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bispecific Antibodies Market Sales by Application (2019-2024)
7.3 Global Bispecific Antibodies Market Size (M USD) by Application (2019-2024)
7.4 Global Bispecific Antibodies Sales Growth Rate by Application (2019-2024)
8 Bispecific Antibodies Market Segmentation by Region
8.1 Global Bispecific Antibodies Sales by Region
8.1.1 Global Bispecific Antibodies Sales by Region
8.1.2 Global Bispecific Antibodies Sales Market Share by Region
8.2 North America
8.2.1 North America Bispecific Antibodies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bispecific Antibodies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bispecific Antibodies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bispecific Antibodies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bispecific Antibodies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche Holding AG
9.1.1 Roche Holding AG Bispecific Antibodies Basic Information
9.1.2 Roche Holding AG Bispecific Antibodies Product Overview
9.1.3 Roche Holding AG Bispecific Antibodies Product Market Performance
9.1.4 Roche Holding AG Business Overview
9.1.5 Roche Holding AG Bispecific Antibodies SWOT Analysis
9.1.6 Roche Holding AG Recent Developments
9.2 GenScript
9.2.1 GenScript Bispecific Antibodies Basic Information
9.2.2 GenScript Bispecific Antibodies Product Overview
9.2.3 GenScript Bispecific Antibodies Product Market Performance
9.2.4 GenScript Business Overview
9.2.5 GenScript Bispecific Antibodies SWOT Analysis
9.2.6 GenScript Recent Developments
9.3 Sino Biological Inc.
9.3.1 Sino Biological Inc. Bispecific Antibodies Basic Information
9.3.2 Sino Biological Inc. Bispecific Antibodies Product Overview
9.3.3 Sino Biological Inc. Bispecific Antibodies Product Market Performance
9.3.4 Sino Biological Inc. Bispecific Antibodies SWOT Analysis
9.3.5 Sino Biological Inc. Business Overview
9.3.6 Sino Biological Inc. Recent Developments
9.4 Creative-Biolabs
9.4.1 Creative-Biolabs Bispecific Antibodies Basic Information
9.4.2 Creative-Biolabs Bispecific Antibodies Product Overview
9.4.3 Creative-Biolabs Bispecific Antibodies Product Market Performance
9.4.4 Creative-Biolabs Business Overview
9.4.5 Creative-Biolabs Recent Developments
9.5 AbbVie Inc.
9.5.1 AbbVie Inc. Bispecific Antibodies Basic Information
9.5.2 AbbVie Inc. Bispecific Antibodies Product Overview
9.5.3 AbbVie Inc. Bispecific Antibodies Product Market Performance
9.5.4 AbbVie Inc. Business Overview
9.5.5 AbbVie Inc. Recent Developments
9.6 Kymab
9.6.1 Kymab Bispecific Antibodies Basic Information
9.6.2 Kymab Bispecific Antibodies Product Overview
9.6.3 Kymab Bispecific Antibodies Product Market Performance
9.6.4 Kymab Business Overview
9.6.5 Kymab Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Bispecific Antibodies Basic Information
9.7.2 AstraZeneca Bispecific Antibodies Product Overview
9.7.3 AstraZeneca Bispecific Antibodies Product Market Performance
9.7.4 AstraZeneca Business Overview
9.7.5 AstraZeneca Recent Developments
9.8 BIOCYTOGEN
9.8.1 BIOCYTOGEN Bispecific Antibodies Basic Information
9.8.2 BIOCYTOGEN Bispecific Antibodies Product Overview
9.8.3 BIOCYTOGEN Bispecific Antibodies Product Market Performance
9.8.4 BIOCYTOGEN Business Overview
9.8.5 BIOCYTOGEN Recent Developments
9.9 Amgen Inc.
9.9.1 Amgen Inc. Bispecific Antibodies Basic Information
9.9.2 Amgen Inc. Bispecific Antibodies Product Overview
9.9.3 Amgen Inc. Bispecific Antibodies Product Market Performance
9.9.4 Amgen Inc. Business Overview
9.9.5 Amgen Inc. Recent Developments
9.10 Pfizer Inc.
9.10.1 Pfizer Inc. Bispecific Antibodies Basic Information
9.10.2 Pfizer Inc. Bispecific Antibodies Product Overview
9.10.3 Pfizer Inc. Bispecific Antibodies Product Market Performance
9.10.4 Pfizer Inc. Business Overview
9.10.5 Pfizer Inc. Recent Developments
9.11 Novartis AG
9.11.1 Novartis AG Bispecific Antibodies Basic Information
9.11.2 Novartis AG Bispecific Antibodies Product Overview
9.11.3 Novartis AG Bispecific Antibodies Product Market Performance
9.11.4 Novartis AG Business Overview
9.11.5 Novartis AG Recent Developments
9.12 Johnson and Johnson
9.12.1 Johnson and Johnson Bispecific Antibodies Basic Information
9.12.2 Johnson and Johnson Bispecific Antibodies Product Overview
9.12.3 Johnson and Johnson Bispecific Antibodies Product Market Performance
9.12.4 Johnson and Johnson Business Overview
9.12.5 Johnson and Johnson Recent Developments
9.13 ProteoGenix
9.13.1 ProteoGenix Bispecific Antibodies Basic Information
9.13.2 ProteoGenix Bispecific Antibodies Product Overview
9.13.3 ProteoGenix Bispecific Antibodies Product Market Performance
9.13.4 ProteoGenix Business Overview
9.13.5 ProteoGenix Recent Developments
10 Bispecific Antibodies Market Forecast by Region
10.1 Global Bispecific Antibodies Market Size Forecast
10.2 Global Bispecific Antibodies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bispecific Antibodies Market Size Forecast by Country
10.2.3 Asia Pacific Bispecific Antibodies Market Size Forecast by Region
10.2.4 South America Bispecific Antibodies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bispecific Antibodies by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Bispecific Antibodies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Bispecific Antibodies by Type (2025-2030)
11.1.2 Global Bispecific Antibodies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Bispecific Antibodies by Type (2025-2030)
11.2 Global Bispecific Antibodies Market Forecast by Application (2025-2030)
11.2.1 Global Bispecific Antibodies Sales (Kilotons) Forecast by Application
11.2.2 Global Bispecific Antibodies Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings